{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:24:00Z","timestamp":1778750640439,"version":"3.51.4"},"reference-count":45,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005416","name":"Research Council of Norway","doi-asserted-by":"crossref","award":["262700"],"award-info":[{"award-number":["262700"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NordForsk Nordic Program on Health and Welfare","award":["83539"],"award-info":[{"award-number":["83539"]}]},{"DOI":"10.13039\/100016190","name":"Trond Mohn Foundation","doi-asserted-by":"crossref","award":["TMF2024TMT03"],"award-info":[{"award-number":["TMF2024TMT03"]}],"id":[{"id":"10.13039\/100016190","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005416","name":"Research Council of Norway","doi-asserted-by":"crossref","award":["328615"],"award-info":[{"award-number":["328615"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2026,1,10]]},"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>High-dose folic acid supplementation is recommended for women using antiseizure medication (ASMs) to reduce risk of major congenital anomalies (MCAs) in offspring, but evidence is lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a sequential target trial emulation using nationwide register data from Denmark, Iceland, Norway, and Sweden (1997\u20132020). Eligible women using ASMs were included and classified as initiators or non-initiators based on whether they filled prescription for high-dose folic acid within one week of inclusion. Risk difference (RD) and risk ratio (RR) for MCAs diagnosed before one year of age in offspring were estimated for initiators of high-dose folic acid (4 or 5 mg\/day) supplementation in three periconceptional periods (13-52 weeks before, 1-12 weeks before, and 1-12 weeks after pregnancy onset) compared with non-initiators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 18 255, 13 619, and 12 365 eligible pregnancies and identified 1047 (5.7%), 521 (3.8%) and 1778 (14.4%) initiators of high-dose folic acid in the three periods, respectively. Initiation of high-dose folic acid 1\u201312\u2009weeks before pregnancy was associated with a lower prevalence of MCA in offspring (2.6% vs 4.8% among non-initiators), corresponding to an absolute risk reduction of 2.2\u2009percentage points (95% CI 0.5 to 3.5) and a 45% relative risk reduction (RR=0.55, 95%\u2009CI 0.25 to 0.91). No risk reduction was observed with initiation 1\u201312\u2009weeks after (RR=1.27, 95%\u2009CI 0.94 to 1.64) or 13\u201352\u2009weeks before (RR=0.99, 95%\u2009CI 0.65 to 1.36) pregnancy onset.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Initiation of high-dose folic acid in the 12\u2009weeks before pregnancy was associated with a reduced risk of MCA in offspring of women using ASMs while initiation in the 12 weeks after pregnancy onset was not.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Research protocol registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/osf.io\/vph2n\/?view_only=c9361e4996eb4c4da32fc878f2fbf5b9\">https:\/\/osf.io\/vph2n\/?view_only=c9361e4996eb4c4da32fc878f2fbf5b9<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jnnp-2025-337395","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:00:12Z","timestamp":1774350012000},"page":"542-552","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Timing of high-dose folic acid supplementation in the periconceptional period among women taking antiseizure medications and risk of major congenital anomalies: a target trial emulation"],"prefix":"10.1136","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6905-0503","authenticated-orcid":false,"given":"Yuelian","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Neurology, Aarhus University Hospital, Affiliated Member of Epi-Care, Aarhus, Denmark"},{"name":"Department of Clinical Medicine, University of Bergen, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silje","family":"Alvestad","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Bergen, Bergen, Norway"},{"name":"National Center for Epilepsy, Oslo University Hospital, Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7300-0488","authenticated-orcid":false,"given":"Jacqueline M","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway"},{"name":"Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2289-0978","authenticated-orcid":false,"given":"Jannicke","family":"Igland","sequence":"additional","affiliation":[{"name":"Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway"},{"name":"Department of Neurology, Haukeland University Hospital, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6522-5102","authenticated-orcid":false,"given":"Nils Erik","family":"Gilhus","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Bergen, Bergen, Norway"},{"name":"Department of Neurology, Haukeland University Hospital, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e5kon M","family":"Vegrim","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Bergen, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torbj\u00f6rn","family":"Tomson","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob","family":"Christensen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Aarhus University Hospital, Affiliated Member of Epi-Care, Aarhus, Denmark"},{"name":"Department of Clinical Medicine, Aarhus University, Aarhus, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7631-4749","authenticated-orcid":false,"given":"Maarit K","family":"Leinonen","sequence":"additional","affiliation":[{"name":"Department of Data and Analytics, Finnish Institute for Health and Welfare, Helsinki, Finland"},{"name":"Teratology Information Service, Emergency Medicine and Services, University of Helsinki and Helsinki University Hospital, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8254-7525","authenticated-orcid":false,"given":"Mika","family":"Gissler","sequence":"additional","affiliation":[{"name":"Department of Data and Analytics, Finnish Institute for Health and Welfare, Helsinki, Finland"},{"name":"Institute of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helga","family":"Zoega","sequence":"additional","affiliation":[{"name":"Centre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjav\u00edk, Iceland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1273-0110","authenticated-orcid":false,"given":"Neda","family":"Razaz","sequence":"additional","affiliation":[{"name":"Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institute, Solna, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie Werenberg","family":"Dreier","sequence":"additional","affiliation":[{"name":"National Centre for Register-Based Research, Aarhus University, Aarhus, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marte-Helene","family":"Bj\u00f8rk","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Bergen, Bergen, Norway"},{"name":"Department of Neurology, Haukeland University Hospital, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"2026051402050518000_97.6.542.1","article-title":"Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child","volume":"8","author":"Bromley","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"2026051402050518000_97.6.542.2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/ana.26561","article-title":"Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations","volume":"93","author":"Cohen","year":"2023","journal-title":"Ann Neurol"},{"key":"2026051402050518000_97.6.542.3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamaneurol.2024.0258","article-title":"Risk of Major Congenital Malformations and Exposure to Antiseizure Medication Monotherapy","volume":"81","author":"Battino","year":"2024","journal-title":"JAMA Neurol"},{"key":"2026051402050518000_97.6.542.4","unstructured":"Position statement on the use of valproate by women of childbearing potential. 2021. Available: https:\/\/aesnet.org\/about\/about-aes\/position-statements\/position-statement-on-the-use-of-valproate-by-women-of-childbearing-potential?utm_source=chatgpt.com"},{"key":"2026051402050518000_97.6.542.5","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1111\/epi.17969","article-title":"Prescribing patterns for higher dose folic acid in pregnant women with epilepsy treated with antiseizure medication","volume":"65","author":"Vegrim","year":"2024","journal-title":"Epilepsia"},{"key":"2026051402050518000_97.6.542.6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10309-023-00602-3","article-title":"Pregnancy, folic acid, and antiseizure medication","volume":"36","author":"Bj\u00f8rk","year":"2023","journal-title":"Clin Epileptol"},{"key":"2026051402050518000_97.6.542.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2009.02130.x"},{"key":"2026051402050518000_97.6.542.8","doi-asserted-by":"crossref","first-page":"110064","DOI":"10.1016\/j.yebeh.2024.110064","article-title":"Periconceptional folic acid supplementation for women with epilepsy: A systematic review of the literature","volume":"161","author":"Peng","year":"2024","journal-title":"Epilepsy Behav"},{"key":"2026051402050518000_97.6.542.9","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/epi4.12420","article-title":"Global Survey of Guidelines for the Management of Epilepsy in Pregnancy: A report from the International League Against Epilepsy Task Force on Women and Pregnancy","volume":"5","author":"Tomson","year":"2020","journal-title":"Epilepsia Open"},{"key":"2026051402050518000_97.6.542.10","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/jamaneurol.2022.2977","article-title":"Cancer Risk in Children of Mothers With Epilepsy and High-Dose Folic Acid Use During Pregnancy","volume":"79","author":"Vegrim","year":"2022","journal-title":"JAMA Neurol"},{"key":"2026051402050518000_97.6.542.11","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1001\/jamaneurol.2023.0674","article-title":"Prenatal Exposure to Antiseizure Medication and Incidence of Childhood- and Adolescence-Onset Psychiatric Disorders","volume":"80","author":"Dreier","year":"2023","journal-title":"JAMA Neurol"},{"key":"2026051402050518000_97.6.542.12","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209279","article-title":"Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication","volume":"102","author":"Pack","year":"2024","journal-title":"Neurology (ECronicon)"},{"key":"2026051402050518000_97.6.542.13","unstructured":"Service UTI . UKTIS official position statement high-dose folic acid (fa) use in pregnancy and risk of childhood cancer (vegrim et al., 2022). 2023. Available: https:\/\/uktis.org\/wp-content\/uploads\/2025\/02\/UKTIS-OPS-High-dose-folic-acid-in-women-with-epilepsy-and-offspring-cancer-risks-1.pdf?utm_source=chatgpt.com"},{"key":"2026051402050518000_97.6.542.14","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwv254"},{"key":"2026051402050518000_97.6.542.15","doi-asserted-by":"publisher","DOI":"10.7326\/ANNALS-24-01871"},{"key":"2026051402050518000_97.6.542.16","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jamaneurol.2022.1269","article-title":"Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability","volume":"79","author":"Bj\u00f8rk","year":"2022","journal-title":"JAMA Neurol"},{"key":"2026051402050518000_97.6.542.17","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2147\/CLEP.S314959","article-title":"Nordic Health Registry-Based Research: A Review of Health Care Systems and Key Registries","volume":"13","author":"Laugesen","year":"2021","journal-title":"Clin Epidemiol"},{"key":"2026051402050518000_97.6.542.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2407586"},{"key":"2026051402050518000_97.6.542.19","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-023-02000-9","article-title":"Implementation of the trial emulation approach in medical research: a scoping review","volume":"23","author":"Scola","year":"2023","journal-title":"BMC Med Res Methodol"},{"key":"2026051402050518000_97.6.542.20","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0000000000001601"},{"key":"2026051402050518000_97.6.542.21","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000207996","article-title":"Comparative Risk of Major Congenital Malformations With Antiseizure Medication Combinations vs Valproate Monotherapy in Pregnancy","volume":"102","author":"Cohen","year":"2024","journal-title":"Neurology (ECronicon)"},{"key":"2026051402050518000_97.6.542.22","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2024.100849","article-title":"Prenatal exposure to antiseizure medications and fetal growth: a population-based cohort study from the Nordic countries","volume":"38","author":"Christensen","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"2026051402050518000_97.6.542.23","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.13319"},{"key":"2026051402050518000_97.6.542.24","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.0000000000000152"},{"key":"2026051402050518000_97.6.542.25","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(84)90119-9"},{"key":"2026051402050518000_97.6.542.26","doi-asserted-by":"publisher","DOI":"10.1053\/seiz.1999.0325"},{"key":"2026051402050518000_97.6.542.27","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/bdr2.1579","article-title":"Periconceptional folic acid and risk for neural tube defects among higher risk pregnancies","volume":"111","author":"Petersen","year":"2019","journal-title":"Birth Defects Res"},{"key":"2026051402050518000_97.6.542.28","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/153.10.961"},{"key":"2026051402050518000_97.6.542.29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011303432204"},{"key":"2026051402050518000_97.6.542.30","unstructured":"Singh R , Munakomi S . Embryology, neural tube. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2023."},{"key":"2026051402050518000_97.6.542.31","doi-asserted-by":"publisher","DOI":"10.1024\/0300-9831.79.2.61"},{"key":"2026051402050518000_97.6.542.32","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30107-8"},{"key":"2026051402050518000_97.6.542.33","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/ajcn\/84.5.1134","article-title":"Patterns and predictors of folic acid supplement use among pregnant women: the Norwegian Mother and Child Cohort Study","volume":"84","author":"Nilsen","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"2026051402050518000_97.6.542.34","first-page":"421","article-title":"Optimal serum and red blood cell folate concentrations in women of reproductive age for prevention of neural tube defects: World Health Organization guidelines","volume":"64","author":"Cordero","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026051402050518000_97.6.542.35","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jogc.2022.04.004","article-title":"Guideline No. 427: Folic Acid and Multivitamin Supplementation for Prevention of Folic Acid-Sensitive Congenital Anomalies","volume":"44","author":"Wilson","year":"2022","journal-title":"J Obstet Gynaecol Can"},{"key":"2026051402050518000_97.6.542.36","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90133-a"},{"key":"2026051402050518000_97.6.542.37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S2215-0366(15)00450-2","article-title":"Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2\u2008\u00d7\u20082 factorial randomised trial","volume":"3","author":"Geddes","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"2026051402050518000_97.6.542.38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2025.01.019","article-title":"Is lamotrigine a teratogen?","volume":"126","author":"Vajda","year":"2025","journal-title":"Seizure"},{"key":"2026051402050518000_97.6.542.39","unstructured":"Hern\u00e1n M . Causal Inference: What If. Boca Raton: Chapman & Hall\/CRC, 2020."},{"key":"2026051402050518000_97.6.542.40","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwg231"},{"key":"2026051402050518000_97.6.542.41","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e3181d61eeb"},{"key":"2026051402050518000_97.6.542.42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2113319"},{"key":"2026051402050518000_97.6.542.43","article-title":"Folic acid supplementation in pregnant women","volume":"57","author":"Rasmussen","year":"2010","journal-title":"Dan Med Bull"},{"key":"2026051402050518000_97.6.542.44","doi-asserted-by":"crossref","DOI":"10.3390\/nu13124422","article-title":"Efficacy of 4.0 mg versus 0.4 mg Folic Acid Supplementation on the Reproductive Outcomes: A Randomized Controlled Trial","volume":"13","author":"Bortolus","year":"2021","journal-title":"Nutrients"},{"key":"2026051402050518000_97.6.542.45","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102366","article-title":"Global heterogeneity in folic acid fortification policies and implications for prevention of neural tube defects and stroke: a systematic review","volume":"67","author":"Quinn","year":"2024","journal-title":"EClinicalMedicine"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2025-337395","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:06:04Z","timestamp":1778749564000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2025-337395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":45,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,5,14]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1136\/jnnp-2025-337395"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2025-337395","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]}}}